Evidence map›Paper›PMID 34613797›Full record

ArticleJCO oncology practice2022

Refining Patient-Centered Measures of End-of-Life Care Quality for Children With Cancer.

Prasanna Ananth, Sophia Mun, Noora Reffat, Soo Jung Kang, Sarah Pitafi, Xiaomei Ma, Cary P Gross, Joanne Wolfe

Abstract read
In one paragraph

Article in JCO oncology practice, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Prasanna AnanthDepartment of Pediatrics, Yale School of Medicine, New Haven, CT.ORCID 0000-0002-5614-7445
Sophia MunYale Cancer Outcomes, Public Policy and Effectiveness Research (COPPER) Center, New Haven, CT.ORCID 0000-0002-9972-9824
Noora ReffatYale Cancer Outcomes, Public Policy and Effectiveness Research (COPPER) Center, New Haven, CT.
Soo Jung KangYale Cancer Outcomes, Public Policy and Effectiveness Research (COPPER) Center, New Haven, CT.ORCID 0000-0003-1482-3086
Sarah PitafiYale Cancer Outcomes, Public Policy and Effectiveness Research (COPPER) Center, New Haven, CT.
Xiaomei MaYale Cancer Outcomes, Public Policy and Effectiveness Research (COPPER) Center, New Haven, CT.
Cary P GrossYale Cancer Outcomes, Public Policy and Effectiveness Research (COPPER) Center, New Haven, CT.ORCID 0000-0002-4974-935X
Joanne WolfeDepartment of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, MA.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
The Pediatric Advanced Cancer Experience (PACE): Measuring Quality of End-of-Life Care for Children with CancerK08CA259222 · NCI · YALE UNIVERSITY · PI ANANTH, PRASANNA J · 2021 to 2025
$1.1M
NCATS NIH HHS UL1 TR001863NCI NIH HHS K08 CA259222NCI NIH HHS L40 CA231699
6 · The paper itself

Abstract

purposeThere are no existing quality measures (QMs) to optimize end-of-life care for children with cancer. Previously, we developed a set of 26 candidate QMs. Our primary objective in this study was to achieve stakeholder consensus on priority measures.

methodsWe conducted an iterative, cross-sectional electronic survey, using a modified Delphi method to build consensus among clinician and family stakeholders. In each of the two rounds of surveys, stakeholders were asked to rate QMs on a 9-point Likert scale, on the basis of perceived importance. Health care professionals were additionally asked to rate measures on perceived feasibility. After each round, we computed median scores on importance and feasibility of measurement, retaining QMs with median importance scores ≥ 8.

resultsTwenty-five participants completed both rounds of the survey. In round 1, participants were asked to rate 26 QMs; nine QMs, including QMs pertaining to health care use, were removed because of median importance scores < 8. Two new measures were proposed for consideration in round 2, on the basis of participant feedback. Following round 2, 17 QMs were ultimately retained. QMs related to symptom screening and palliative care consultation were rated highly in importance and feasibility. QMs related to communication were rated highly important, yet less feasible. Measuring whether a patient's needs were heard by their health care team was rated among the least feasible.

conclusionChildhood cancer stakeholders prioritized QMs pertaining to patient-reported outcomes, deeming measures of health care resource use less important. Future research should seek to develop novel tools for quality assessment to enhance feasibility of implementing priority measures.

Indexed as

NeoplasmsTerminal CareChildCross-Sectional StudiesDelphi TechniqueHumansPatient-Centered Care

Identifiers

PMID34613797
PMCPMC8932486

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.